Initial STP705 Phase I Trial Results Show Fat Reduction
Sirnaomics' STP705 is a drug candidate for fat reduction in adults undergoing abdominoplasty. The STP705 Phase I trial results show signs of efficacy and safety.
Sirnaomics' STP705 is a drug candidate for fat reduction in adults undergoing abdominoplasty. The STP705 Phase I trial results show signs of efficacy and safety.
Older women undergoing breast reconstruction after mastectomy face slightly higher risks of complications but report better psychological well-being despite lower satisfaction with breast appearance, highlighting the need to weigh age-related risks and benefits when considering surgery.